Photodynamic and Antibiotic Therapy Impair the Pathogenesis of Enterococcus faecium in a Whole Animal Insect Model

Enterococcus faecium has emerged as one of the most important pathogens in healthcare-associated infections worldwide due to its intrinsic and acquired resistance to many antibiotics, including vancomycin. Antimicrobial photodynamic therapy (aPDT) is an alternative therapeutic platform that is currently under investigation for the control and treatment of infections. PDT is based on the use of photoactive dye molecules, widely known as photosensitizer (PS). PS, upon irradiation with visible light, produces reactive oxygen species that can destroy lipids and proteins causing cell death. We employed Galleria mellonella (the greater wax moth) caterpillar fatally infected with E. faecium to develop an invertebrate host model system that can be used to study the antimicrobial PDT (alone or combined with antibiotics). In the establishment of infection by E. faecium in G. mellonella, we found that the G. mellonella death rate was dependent on the number of bacterial cells injected into the insect hemocoel and all E. faecium strains tested were capable of infecting and killing G. mellonella. Antibiotic treatment with ampicillin, gentamicin or the combination of ampicillin and gentamicin prolonged caterpillar survival infected by E. faecium (P = 0.0003, P = 0.0001 and P = 0.0001, respectively). In the study of antimicrobial PDT, we verified that methylene blue (MB) injected into the insect followed by whole body illumination prolonged the caterpillar survival (P = 0.0192). Interestingly, combination therapy of larvae infected with vancomycin-resistant E. faecium, with antimicrobial PDT followed by vancomycin, significantly prolonged the survival of the caterpillars when compared to either antimicrobial PDT (P = 0.0095) or vancomycin treatment alone (P = 0.0025), suggesting that the aPDT made the vancomycin resistant E. faecium strain more susceptible to vancomycin action. In summary, G. mellonella provides an invertebrate model host to study the antimicrobial PDT and to explore combinatorial aPDT-based treatments

The Transcriptome of the Nosocomial Pathogen Enterococcus faecalis V583 Reveals Adaptive Responses to Growth in Blood

gains access to the bloodstream and establishes a persistent infection is not well understood.. infections

Developing and user testing new pharmacy label formats—A study to inform labelling standards

Background Dispensed prescription medicine labels (prescription labels) are important information sources supporting safe and appropriate medicines use. Objective To develop and user test patient-centred prescription label formats. Methods Five stages: developing 12 labels for four fictitious medicines of varying dosage forms; diagnostic user testing of labels (Round 1) with 40 consumers (each testing three labels); iterative label revision, and development of Round 2 labels (n = 7); user testing of labels (Round 2) with 20 consumers (each testing four labels); labelling recommendations. Evaluated labels stated the active ingredient and brand name, using various design features (eg upper case and bold). Dosing was expressed differently across labels: frequency of doses/day, approximate times of day (eg morning), explicit times (eg 7 to 9 AM), and/or explicit dosing interval. Participants’ ability to find and understand medicines information and plan a dosing schedule were assessed. Results Participants demonstrated satisfactory ability to find and understand the dosage for all label formats. Excluding active ingredient and dosing schedule, 14/19 labels (8/12 in Round 1; 6/7 in Round 2) met industry standard on performance. Participants’ ability to correctly identify the active ingredient varied, with clear medicine name sign-posting enabling all participants evaluating these labels to find and understand the active ingredient. When planning a dosing schedule, doses were correctly spaced if the label stated a dosing interval, or frequency of doses/day. Two-thirds planned appropriate dosing schedules using a dosing table. Conclusions Effective prescription label formatting and sign-posting of active ingredient improved communication of information on labels, potentially supporting safe medicines use. Patient and Public Involvement Consumers actively contributed to the development of dispensed prescription medicine labels. Feedback from consumers following the first round was incorporated in revisions of the labels for the next round. Patient and public involvement in this study was critical to the development of readable and understandable dispensed prescription medicine labels

Comparative Genomic Analysis of Pathogenic and Probiotic Enterococcus faecalis Isolates, and Their Transcriptional Responses to Growth in Human Urine

Urinary tract infection (UTI) is the most common infection caused by enterococci, and Enterococcus faecalis accounts for the majority of enterococcal infections. Although a number of virulence related traits have been established, no comprehensive genomic or transcriptomic studies have been conducted to investigate how to distinguish pathogenic from non-pathogenic E. faecalis in their ability to cause UTI. In order to identify potential genetic traits or gene regulatory features that distinguish pathogenic from non-pathogenic E. faecalis with respect to UTI, we have performed comparative genomic analysis, and investigated growth capacity and transcriptome profiling in human urine in vitro. Six strains of different origins were cultivated and all grew readily in human urine. The three strains chosen for transcriptional analysis showed an overall similar response with respect to energy and nitrogen metabolism, stress mechanism, cell envelope modifications, and trace metal acquisition. Our results suggest that citrate and aspartate are significant for growth of E. faecalis in human urine, and manganese appear to be a limiting factor. The majority of virulence factors were either not differentially regulated or down-regulated. Notably, a significant up-regulation of genes involved in biofilm formation was observed. Strains from different origins have similar capacity to grow in human urine. The overall similar transcriptional responses between the two pathogenic and the probiotic strain suggest that the pathogenic potential of a certain E. faecalis strain may to a great extent be determined by presence of fitness and virulence factors, rather than the level of expression of such traits

Bacteria–photocatalyst sheet for sustainable carbon dioxide utilization

The clean conversion of carbon dioxide and water to a single multicarbon product and O2 using sunlight via photocatalysis without the assistance of organic additives or electricity remains an unresolved challenge. Here we report a bio-abiotic hybrid system with the nonphotosynthetic, CO2-fixing acetogenic bacterium, Sporomusa ovata (S. ovata) grown on a scalable and cost-effective photocatalyst sheet consisting of a pair of particulate semiconductors (La and Rh co-doped SrTiO3 (SrTiO3:La,Rh) and Mo-doped BiVO4 (BiVO4:Mo)). The biohybrid effectively produces acetate (CH3COO–) and oxygen (O2) using only sunlight, CO2 and H2O, achieving a solar-to-acetate conversion efficiency of 0.7%. The photocatalyst sheet oxidises water to O2 and provides electrons and hydrogen (H2) to S. ovata for the selective synthesis of CH3COO– from CO2. To demonstrate the utility in a closed carbon cycle, the solar-generated acetate was used directly as feedstock in a bioelectrochemical system for electricity generation. These semi-biological systems thus offer a promising strategy for sustainably and cleanly fixing CO2 and closing the carbon cycle

Electrocatalytic and Solar-Driven Reduction of Aqueous CO<inf>2</inf>with Molecular Cobalt Phthalocyanine-Metal Oxide Hybrid Materials

Electrolytic and solar-driven reduction of CO2 to CO using heterogenized molecular catalysts are promising approaches toward the production of a key chemical feedstock, as well as mitigating CO2 emissions. Here, we report a molecular cobalt phthalocyanine catalyst bearing four phosphonic acid anchoring groups (CoPcP) that can be immobilized on metal oxide electrodes. A hybrid electrode with CoPcP on mesoporous TiO2 (mesoTiO2) converts CO2 to CO in aqueous electrolyte solution at a near-neutral pH (7.3) with high selectivity and a turnover number for CO (TONCO) of 1949 ± 5 after 2 h of controlled-potential electrolysis at −1.09 V against the standard hydrogen electrode (∼550 mV overpotential). In situ UV–visible spectroelectrochemical investigations alluded to a catalytic mechanism that involves non-rate-limiting CO2 binding to the doubly reduced catalyst. Finally, the integration of the mesoTiO2|CoPcP assembly with a p-type silicon (Si) photoelectrode allowed the construction of a benchmark precious-metal-free molecular photocathode that achieves a TONCO of 939 ± 132 with 66% selectivity for CO (CO/H2 = 1.9) under fully aqueous conditions. The electrocatalytic and photoelectrochemical (PEC) activities of CoPcP were compared to those of state of the art synthetic and enzymatic CO2 reduction catalysts, demonstrating the excellent performance of CoPcP and its suitability for integration in tandem PEC devices